Middle East & AfricaENPublic regulatory overview
Israel
Market Overview Population: Approximately 9.5 million (2024) Healthcare System: Universal mandatory health insurance (the Kupot Holim system — four major health funds: Clalit, Macc...
Updated: 2026-05-04
You are viewing the public excerpt. During the limited-time free period, sign in to view the complete country report.
AI Citation Summary
- Country: Israel
- Product line: Medical devices
- Regulator / source: Market Characteristics: A high-technology medical market with high per capita healthcare expenditure; a significant proportion of private hospitals and outpatient clinics; strong demand for innovative medical devices; a well-developed domestic medical technology industry (numerous startups and multinational R&D centers); regulatory quality aligned with Europe and the United States
- Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
- Typical timeline: 4. AMAR reviews document completeness (approximately 1–2 months); may issue a Deficiency Letter
- Key fees: Registration Fees
- Local requirement: 2. Appoint a licensed Israeli Authorized Representative (IAR / נציג מורשה) in Israel
- Official sources: Official regulator portals and source links are listed in the country report where available.
- Last verified: 2026-05-04
- Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
- Preferred citation: MedTech Atlas
Market Overview
- Population: Approximately 9.5 million (2024)
- Healthcare System: Universal mandatory health insurance (the Kupot Holim system — four major health funds: Clalit, Maccabi, Meuhedet, Leumit), with coexisting public and private sectors and extremely high coverage rates
- Market Characteristics: A high-technology medical market with high per capita healthcare expenditure; a significant proportion of private hospitals and outpatient clinics; strong demand for innovative medical devices; a well-developed domestic medical technology industry (numerous startups and multinational R&D centers); regulatory quality aligned with Europe and the United States
- Regulatory Maturity: Highly mature; the regulatory framework is benchmarked against EU MDR; broadly recognizes FDA 510(k)/PMA and EU CE marking as reference market approvals
Regulatory Authority
- Competent Authority: Ministry of Health of Israel (MOH / משרד הבריאות), through the Medical Technology, Cosmetics and Non-Ionizing Radiation Division (MTCNIR); specific registration matters are handled by AMAR (Agaf Meizug Rishum / אגף מאיזון רישום — the Medical Device Registration Directorate)
- Official Portal: https://www.health.gov.il/English/Topics/MedicalEquipment/Pages/default.aspx (English); AMAR online submission system: https://amar.health.gov.il
- Key Regulations:
- Medical Devices Law 5772-2012
- Medical Devices Regulations 5774-2014
- MOH Circulars / Director General Circulars: continuously updated technical requirements
- IVDs are separately regulated under the In Vitro Diagnostic Devices Regulations
Device Classification System
...